Is C83.3A a billable ICD-10-CM code?

Yes. C83.3A is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does C83.3A sit in the tabular list?

Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).

C83.3A

C83.3A — Diffuse large B-cell lymphoma, in remission

Billable / specific codeICD-10-CM

C83.3A is a billable, specific ICD-10-CM code for diffuse large b-cell lymphoma, in remission. It is valid for submission on a claim.

Risk adjustment

C83.3A risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 20 Lung and Other Severe Cancers1.136 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

C83.3A is named in 38 Medicare coverage policies — 38 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52370Billing and Coding: Bevacizumab and biosimilars
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article
A52479Oral Anticancer Drugs - Policy Article

Related codes at this level

Codes that share C83.3. If C83.3A is not quite right, the correct code is usually one of these.

Questions about C83.3A

Is C83.3A a billable ICD-10-CM code?: Yes. C83.3A is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does C83.3A sit in the tabular list?: Neoplasms (C00-D49), in the block Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96).